Rosuko Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium
Prescription medication
Korea Novartis Co., Ltd.
MFDS item code 201404473 · Approved 2014.09.30
This product's status changed to Approval withdrawn on 2023.06.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used as an adjunct in patients with primary hypercholesterolemia and mixed hyperlipidemia where dietary management and exercise alone are inadequate. It also helps patients with homozygous familial hypercholesterolemia when used in conjunction with other lipid-lowering therapies. It lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis, and is useful in managing children aged 10 and older with high LDL cholesterol levels due to heterozygous familial hypercholesterolemia. Additionally, it is used as an adjunct to dietary management in patients with primary dysbetalipoproteinemia. Furthermore, it contributes to reducing the risk of stroke, myocardial infarction, and vascular revascularization in high-risk groups with elevated high-sensitivity C-reactive protein levels. In summary, this drug is effectively used to lower the risk of hypercholesterolemia and cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The starting dose is 5 milligrams once daily; the dose may be adjusted as a maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response; it may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: Dose adjustment is not required. 4. Patients with renal impairment: Dose adjustment is not required in patients with mild or moderate renal impairment. Do not administer this drug to patients with severe renal impairment. Use particular caution when administering 20mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose is contraindicated in some of these patients.
Age 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, patients who are allergic to this medication, those with severely impaired liver function, patients with muscle disorders, severely impaired kidney function, and pregnant or breastfeeding women should not use this medication. Additionally, women of childbearing potential should only take this medication if they are unlikely to become pregnant and must use appropriate contraceptive methods. This medication can cause muscle-related side effects; therefore, if symptoms of muscle pain or muscle weakness occur, patients must inform their doctor immediately. In particular, patients with reduced kidney function or a history of hypothyroidism or genetic muscle diseases should exercise extra caution. There may be abnormal liver function; hence, patients with a history of liver disease or those consuming alcohol excessively should have regular liver function tests. Concurrently taking this medication with some other medications may increase blood concentrations, thus raising the risk of muscle damage; always consult with a doctor when taking other medications together. Pregnant or breastfeeding women should not take this medication, and women who may become pregnant must use appropriate contraceptive methods. During the course of this medication, blood sugar levels may occasionally rise, so patients at risk for diabetes should regularly monitor their blood sugar levels. In cases of overdose, there is no specific antidote; therefore, treatment should be based on symptoms, while monitoring liver function and muscle enzyme levels. This medication may cause symptoms such as dizziness, so caution is advised when driving or operating machinery. Lastly, if severe rash or allergic reactions occur during the use of this medication, it must be stopped immediately, and medical attention should be sought.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. It is recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. This helps maintain the drug's efficacy over time.
Brown round film-coated tablets
28 tablets (7 tablets/ Alu-Alu x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium
Prescription medication
Korea Novartis Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.